Abstract
We developed a method for the simultaneous analysis of microheterogeneity of human serum IgG, IgA, IgM, IgD, and IgE, and serum protein pattern using cellulose acetate membrane isoelectric focusing, and analyzed in 11 healthy subjects and 67 patients with M protein (17 cases of multiple myeloma [MM] and 50 cases of monoclonal gammopathy of undetermined significance [MGUS]). Using this method, bands indicating the microheterogeneity of each immunoglobulin could clearly be detected. Among healthy subjects, the detected IgG, IgA, and IgM bands did not vary, but the detected IgE and IgD bands did vary. Therefore, IgA, IgM, and IgG were selected for comparison of serum immunoglobulins in MM and in MGUS. In the IgA‐type M protein group, normal IgM and IgG bands were decreased in MM patients compared to MGUS patients, while the M band and other bands were increased in MM patients compared to MGUS patients, but the differences between the two groups were not significant. In the IgG‐type M protein group, normal IgM, IgA, and IgG were significantly decreased in MM patients compared to MGUS patients. We examined the changes in electrophoretic pattern in six MM patients and eight MGUS patients with IgA‐type M protein after neuraminidase treatment. The width of the M band in MM patients with IgA‐type M protein decreased with neuraminidase treatment. On the other hand, the width of the M band in MGUS patients with IgA‐type M protein increased with neuraminidase treatment. We concluded that the decrease of the normal immunoglobulins in MM patients with IgG type M protein could be detected by this method, and IgA type of M protein binding sugar chain were different between MM and MGUS patients. J. Clin. Lab. Anal. 13:145–150, 1999. © 1999 Wiley‐Liss, Inc.
Keywords: human serum immunoglobulin, multiple myeloma, monoclonal gammopathy of undetermined significance
REFERENCES
- 1. Kyle RA. Monoclonal gammopathy of undetermined significance (MGUS). Baillieres Clin Haematol 1995;8:761–781. Medline [DOI] [PubMed] [Google Scholar]
- 2. Kyle RA. Diagnosis and management of multiple myeloma and reated disorders. Prog Hematol 1996;14:257–282. [PubMed] [Google Scholar]
- 3. Kitani T. Multiple myeloma—diagnosis, prognostic factors treatment. Jpn J Clin Hematol 1995;36:471–479. [PubMed] [Google Scholar]
- 4. Cohoen AM, Allalouf D, Bessler M, Djaldetti M, Malachi T, Levinsky H. Sialyltransferase activity and sialic acid levels in multiple myeloma and monoclonal gammopathy. Eur J Haematol 1989;42:289–292. Medline [DOI] [PubMed] [Google Scholar]
- 5. Schipper HI, Prange HW. Cerebrospinal fluid paraprotein in neurological disorders. J Neurol Sci 1984;64:305–314. Medline [DOI] [PubMed] [Google Scholar]
- 6. Fasullo FJ Jr, Fritsche HA Jr, Liu FJ, Hamilton RG. IgG heavy‐chain subclass typing of myeloma paraproteins by isoelectric focusing immunoblot analysis. Clin Chem 1989;35:364–368. Medline [PubMed] [Google Scholar]
- 7. Kamiya HY, Sato Y, Otani H, Kawakami M. Sensitivity in detection of monoclonal immunoglobulins by thin‐layer isoelectric focusing and certain electrophoreses in laboratory use. Microbiol Immunol 1981;25:1067–1076. Medline [DOI] [PubMed] [Google Scholar]
- 8. Toda T, Shiba KS, Cho H, Soon PL, Nakao M, Ohashi M. An improved method of high‐voltage isoelectric focusing on cellulose acetate membranes. Electrophoresis 1988;9:149–150. Medline [DOI] [PubMed] [Google Scholar]
- 9. Shiba K, Toda T, Iijima S, et al. Development of a thermoelectric cooling apparatus for high‐voltage isoelectric focusing on a cellulose acetate membrane. Biol Pharm Bull 1994;17:1317–1320. Medline [DOI] [PubMed] [Google Scholar]
- 10. Iijima S, Shiba K, Inoue J, Yoshida T, Kimura M. Simultaneous analysis of microheterogeneity of immunoglobulins and serum protein fraction using high‐voltage isoelectric focusing on six cellulose acetate membranes. J Clin Lab Anal 1997;11:220–224. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Andersen JK. Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 1984;10:203–209. Medline [DOI] [PubMed] [Google Scholar]
- 12. Blade J, Lopez GA, Rozman C, et al. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Br J Haematol 1992;81:391–394. Medline [DOI] [PubMed] [Google Scholar]
- 13. Giraldo MP, Rubio FD, Perella M, Gracia JA, Bergua JM, Giralt M. Monoclonal gammopathies of undetermined significance. Clinical course and biological aspects of 397 cases. Sangre (Barc) 1991;36:377–382.Medline [PubMed] [Google Scholar]
- 14. Endo T, Mestecky J, Kulhavy R, Kobata A. Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses. Mol Immunol 1994;31:1415–1422. Medline [DOI] [PubMed] [Google Scholar]
- 15. Crook MA, Couchman S, Tutt P. Serum sialic acid in patients with multiple myeloma. Br J Biomed Sci 1996;53:185–1186. Medline [PubMed] [Google Scholar]
- 16. Richard GB, Silberzahn P, Bonnassieux M, Colobert L. Action de la neuraminidase sur les immunoglobulins de type IgA (de myelome). Clin Chim Acta 1968;21:479–484. Medline [DOI] [PubMed] [Google Scholar]
